{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:40Z","timestamp":1787020840902,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672300"],"award-info":[{"award-number":["81672300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Provincial Natural Science Foundation","award":["2019SF-224"],"award-info":[{"award-number":["2019SF-224"]}]},{"name":"the project of the free exploration and innovation project of Xi\u2019an Jiaotong University","award":["xjj2018144"],"award-info":[{"award-number":["xjj2018144"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circular RNAs (circRNAs) are a new type of extensive non-coding RNAs that regulate the activation and progression of different human diseases, including cancer. However, information on the underlying mechanisms and clinical significance of circRNAs in lung squamous cell carcinoma (LUSC) remains scant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression profile of RNAs in 8 LUSC tissues, and 9 healthy lung tissues were assayed using RNA sequencing (RNA-seq) techniques. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to profile the expression of circPVT1 and its relationship with the prognosis of LUSC, i.e., survival analysis. Moreover, in vitro and in vivo experiments were performed to evaluate the impacts of circPVT1 on the growth of tumors. RNA pull-down tests, mass spectrometry, dual-luciferase reporter assessment, and RNA immune-precipitation tests were further conducted to interrogate the cross-talk between circPVT1, HuR, or miR-30d\/e in LUSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our data showed that circPVT1 was upregulated in LUSC tissues, serum, and cell lines. LUSC patients with higher circPVT1 expression exhibited shorter survival rates. The in vivo\n                      <jats:italic>and<\/jats:italic>\n                      in vitro data revealed that circPVT1 promotes the proliferation of LUSC cells. Additionally, mechanistic analysis showed that HuR regulated circPVT1. On the other hand, circPVT1 acted as a competing endogenous RNA (ceRNA) of miR-30d and miR-30e in alleviating the suppressive influences of miR-30d and miR-30e on its target cyclin F (CCNF).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CircPVT1 promotes LUSC progression via HuR\/circPVT1\/miR-30d and miR-30e\/CCNF cascade. Also, it acts as a novel diagnostic biomarker or treatment target of individuals diagnosed with LUSC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-021-01976-w","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:03:08Z","timestamp":1623319388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["CircPVT1 promotes proliferation of lung squamous cell carcinoma by binding to miR-30d\/e"],"prefix":"10.1186","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-7031","authenticated-orcid":false,"given":"Jie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjuan","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"1","key":"1976_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1976_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535\u201346. https:\/\/doi.org\/10.1038\/nrc3775.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1976_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1976_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357. https:\/\/doi.org\/10.1261\/rna.035667.112.","journal-title":"RNA"},{"issue":"6","key":"1976_CR5","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.3390\/ijms15069331","volume":"15","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Tsukahara T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci. 2014;15(6):9331\u201342. https:\/\/doi.org\/10.3390\/ijms15069331.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1976_CR6","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1158\/0008-5472.CAN-14-2218","volume":"75","author":"X Su","year":"2015","unstructured":"Su X, Wang H, Ge W, Yang M, Hou J, Chen T, et al. An in vivo method to identify microRNA targets not predicted by computation algorithms: p21 targeting by miR-92a in Cancer. Cancer Res. 2015;75(14):2875\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2218.","journal-title":"Cancer Res"},{"issue":"3","key":"1976_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-019-1446-z","volume":"10","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Wu F, Wei W, Dang Y, Yang B, Ma X, et al. Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma. Cell Death Dis. 2019;10(3):192. https:\/\/doi.org\/10.1038\/s41419-019-1446-z.","journal-title":"Cell Death Dis"},{"issue":"11","key":"1976_CR8","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/jcmm.13198","volume":"21","author":"L Zhuang","year":"2017","unstructured":"Zhuang L, Shou T, Li K, Gao CL, Duan LC, Fang LZ, et al. MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma. J Cell Mol Med. 2017;21(11):2852\u201362. https:\/\/doi.org\/10.1111\/jcmm.13198.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1976_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.034.","journal-title":"Mol Cell"},{"key":"1976_CR10","doi-asserted-by":"publisher","first-page":"e10168","DOI":"10.15252\/emmm.201810168","volume":"11","author":"HQ Ju","year":"2019","unstructured":"Ju HQ, Zhao Q, Wang F, et al. A circRNA signature predicts postoperative recurrence in stage II\/III colon cancer. Embo Mol Med. 2019;11:e10168.","journal-title":"Embo Mol Med"},{"issue":"1","key":"1976_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-018-0888-8","volume":"17","author":"W Tang","year":"2018","unstructured":"Tang W, Fu K, Sun H, Rong D, Wang H, Cao H. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer. Mol Cancer. 2018;17(1):137. https:\/\/doi.org\/10.1186\/s12943-018-0888-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"1976_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-018-0933-7","volume":"18","author":"R Yang","year":"2019","unstructured":"Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019;18(1):4. https:\/\/doi.org\/10.1186\/s12943-018-0933-7.","journal-title":"Mol Cancer"},{"issue":"1","key":"1976_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13059-019-1685-4","volume":"20","author":"WC Liang","year":"2019","unstructured":"Liang WC, Wong CW, Liang PP, Shi M, Cao Y, Rao ST, et al. Translation of the circular RNA circbeta-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20(1):84. https:\/\/doi.org\/10.1186\/s13059-019-1685-4.","journal-title":"Genome Biol"},{"issue":"12","key":"1976_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1200\/JOP.2017.026716","volume":"13","author":"N Hanna","year":"2017","unstructured":"Hanna N, Johnson D, Temin S, Masters G. Systemic therapy for stage IV non-small-cell lung Cancer: American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract. 2017;13(12):832\u20137. https:\/\/doi.org\/10.1200\/JOP.2017.026716.","journal-title":"J Oncol Pract"},{"key":"1976_CR15","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519\u201325. https:\/\/doi.org\/10.1038\/nature11404.","DOI":"10.1038\/nature11404"},{"issue":"10","key":"1976_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/onc.2016.303","volume":"36","author":"F Chen","year":"2017","unstructured":"Chen F, Zhang Y, Parra E, Rodriguez J, Behrens C, Akbani R, et al. Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. 2017;36(10):1384\u201393. https:\/\/doi.org\/10.1038\/onc.2016.303.","journal-title":"Oncogene"},{"key":"1976_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006.","journal-title":"Cancer Lett"},{"issue":"1","key":"1976_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13059-017-1368-y","volume":"18","author":"L Verduci","year":"2017","unstructured":"Verduci L, Ferraiuolo M, Sacconi A, Ganci F, Vitale J, Colombo T, et al. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53\/YAP\/TEAD transcription-competent complex. Genome Biol. 2017;18(1):237. https:\/\/doi.org\/10.1186\/s13059-017-1368-y.","journal-title":"Genome Biol"},{"issue":"7","key":"1976_CR19","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1093\/nar\/gkw1201","volume":"45","author":"AC Panda","year":"2017","unstructured":"Panda AC, Grammatikakis I, Kim KM, de S, Martindale JL, Munk R, et al. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1. Nucleic Acids Res. 2017;45(7):4021\u201335. https:\/\/doi.org\/10.1093\/nar\/gkw1201.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1976_CR20","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1159\/000495876","volume":"51","author":"X Li","year":"2018","unstructured":"Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H, et al. Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung Cancer. Cell Physiol Biochem. 2018;51(5):2324\u201340. https:\/\/doi.org\/10.1159\/000495876.","journal-title":"Cell Physiol Biochem"},{"key":"1976_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopha.2018.12.007","volume":"111","author":"S Qin","year":"2019","unstructured":"Qin S, Zhao Y, Lim G, Lin H, Zhang X, Zhang X. Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression. Biomed Pharmacother. 2019;111:244\u201350. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.007.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1976_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12943-019-1094-z","volume":"18","author":"F Yang","year":"2019","unstructured":"Yang F, Hu A, Li D, Wang J, Guo Y, Liu Y, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019;18(1):158. https:\/\/doi.org\/10.1186\/s12943-019-1094-z.","journal-title":"Mol Cancer"},{"key":"1976_CR23","doi-asserted-by":"publisher","unstructured":"Li XX, Xiao L, Chung HK, Ma XX, Liu X, Song JL, et al. circPABPN1 Interaction between HuR and Modulates Autophagy in the Intestinal Epithelium by Altering ATG16L1 Translation. Mol Cell Biol. 2020;40(6):e00492\u201319. https:\/\/doi.org\/10.1128\/MCB.00492-19.","DOI":"10.1128\/MCB.00492-19"},{"issue":"11","key":"1976_CR24","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1093\/nar\/gky214","volume":"46","author":"Y Lan","year":"2018","unstructured":"Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L, et al. Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. Nucleic Acids Res. 2018;46(11):5809\u201321. https:\/\/doi.org\/10.1093\/nar\/gky214.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1976_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/15476286.2017.1279788","volume":"14","author":"K Abdelmohsen","year":"2017","unstructured":"Abdelmohsen K, Panda AC, Munk R, Grammatikakis I, Dudekula DB, de S, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017;14(3):361\u20139. https:\/\/doi.org\/10.1080\/15476286.2017.1279788.","journal-title":"RNA Biol"},{"issue":"1","key":"1976_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13046-016-0350-y","volume":"35","author":"Z Ye","year":"2016","unstructured":"Ye Z, Li J, Han X, Hou H, Chen H, Zheng X, et al. TET3 inhibits TGF-beta1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells. J Exp Clin Cancer Res. 2016;35(1):72. https:\/\/doi.org\/10.1186\/s13046-016-0350-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1976_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-017-0615-x","volume":"16","author":"ZY Lin","year":"2017","unstructured":"Lin ZY, Chen G, Zhang YQ, He HC, Liang YX, Ye JH, et al. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1\/c-JUN\/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2017;16(1):48. https:\/\/doi.org\/10.1186\/s12943-017-0615-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"1976_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-019-0999-x","volume":"18","author":"M Zheng","year":"2019","unstructured":"Zheng M, Hou L, Ma Y, Zhou L, Wang F, Cheng B, et al. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Mol Cancer. 2019;18(1):76. https:\/\/doi.org\/10.1186\/s12943-019-0999-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"1976_CR29","doi-asserted-by":"publisher","first-page":"1567219","DOI":"10.1080\/20013078.2019.1567219","volume":"8","author":"T Bjornetro","year":"2019","unstructured":"Bjornetro T, Redalen KR, Meltzer S, et al. An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer. J Extracell Vesicles. 2019;8(1):1567219. https:\/\/doi.org\/10.1080\/20013078.2019.1567219.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"1976_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.lungcan.2013.05.007","volume":"81","author":"A Markou","year":"2013","unstructured":"Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer. 2013;81(3):388\u201396. https:\/\/doi.org\/10.1016\/j.lungcan.2013.05.007.","journal-title":"Lung Cancer"},{"issue":"2","key":"1976_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2015.03.041","volume":"362","author":"D Chen","year":"2015","unstructured":"Chen D, Guo W, Qiu Z, Wang Q, Li Y, Liang L, et al. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Cancer Lett. 2015;362(2):208\u201317. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.041.","journal-title":"Cancer Lett"},{"issue":"12","key":"1976_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10529-017-2428-9","volume":"39","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhang J, Hou S, Cheng Z, Yuan M. Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB. Biotechnol Lett. 2017;39(12):1827\u201334. https:\/\/doi.org\/10.1007\/s10529-017-2428-9.","journal-title":"Biotechnol Lett"},{"issue":"28","key":"1976_CR33","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1038\/onc.2016.491","volume":"36","author":"L Deng","year":"2017","unstructured":"Deng L, Tang J, Yang H, Cheng C, Lu S, Jiang R, et al. MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway. Oncogene. 2017;36(28):3976\u201385. https:\/\/doi.org\/10.1038\/onc.2016.491.","journal-title":"Oncogene"},{"issue":"18","key":"1976_CR34","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-17-3058","volume":"78","author":"M Croset","year":"2018","unstructured":"Croset M, Pantano F, Kan C, et al. miRNA-30 family members inhibit breast Cancer invasion, Osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes. Cancer Res. 2018;78(18):5259\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3058.","journal-title":"Cancer Res"},{"issue":"3","key":"1976_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s13577-018-0223-0","volume":"32","author":"Y Cui","year":"2019","unstructured":"Cui Y, Zhao L, Zhao S, Guo T, Li F, Li Z, et al. MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9. Hum Cell. 2019;32(3):326\u201333. https:\/\/doi.org\/10.1007\/s13577-018-0223-0.","journal-title":"Hum Cell"},{"issue":"2","key":"1976_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.yexcr.2017.11.027","volume":"362","author":"G Xu","year":"2018","unstructured":"Xu G, Cai J, Wang L, Jiang L, Huang J, Hu R, et al. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1\/JAK\/STAT3 signaling. Exp Cell Res. 2018;362(2):268\u201378. https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.027.","journal-title":"Exp Cell Res"},{"issue":"5","key":"1976_CR37","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cell.2012.03.043","volume":"149","author":"V D'Angiolella","year":"2012","unstructured":"D'Angiolella V, Donato V, Forrester FM, Jeong YT, Pellacani C, Kudo Y, et al. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell. 2012;149(5):1023\u201334. https:\/\/doi.org\/10.1016\/j.cell.2012.03.043.","journal-title":"Cell"},{"issue":"6773","key":"1976_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/35003506","volume":"404","author":"H Tanaka","year":"2000","unstructured":"Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature. 2000;404(6773):42\u20139. https:\/\/doi.org\/10.1038\/35003506.","journal-title":"Nature"},{"issue":"15","key":"1976_CR39","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1158\/0008-5472.CAN-12-2085","volume":"73","author":"MJ Murray","year":"2013","unstructured":"Murray MJ, Saini HK, Siegler CA, Hanning JE, Barker EM, van Dongen S, et al. LIN28 expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Cancer Res. 2013;73(15):4872\u201384. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2085.","journal-title":"Cancer Res"},{"issue":"11","key":"1976_CR40","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1517\/14728222.2014.957671","volume":"18","author":"KJ Hatfield","year":"2014","unstructured":"Hatfield KJ, Reikvam H, Bruserud O. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells. Expert Opin Ther Targets. 2014;18(11):1237\u201351. https:\/\/doi.org\/10.1517\/14728222.2014.957671.","journal-title":"Expert Opin Ther Targets"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-021-01976-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:08:06Z","timestamp":1623319686000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-021-01976-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1186\/s13046-021-01976-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All tissue samples were in accordance with the ethical guidelines of the second affiliated hospital of Xi\u2019an Jiaotong University. Written informed consents were obtained from all patients. The ethics approval statements for animal work were provided by Xi\u2019an Jiaotong University Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of the manuscript in Journal of Experimental & Clinical Cancer Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}